Zhuo Liyong, Xu Shijie, Zhang Guozhi, Xing Lihong, Zhang Yu, Ma Zepeng, Wang Jianing, Yin Xiaoping
Department of Radiology, Affiliated Hospital of Hebei University, Baoding 071000, China.
United Imaging Healthcare, Shanghai 201800, China.
Eur J Radiol. 2024 Dec;181:111742. doi: 10.1016/j.ejrad.2024.111742. Epub 2024 Sep 19.
To explore the potential of the deep learning reconstruction (DLR) for ultralow dose calcium scoring CT (CSCT) with simultaneously reduced tube voltage and current.
In this prospective study, seventy-five patients (group A) undergoing routine dose CSCT (120kVp/30mAs) were followed by a low dose (120kVp/20mAs) scan and another 81 (group B) were followed by an ultralow dose (80kVp/20mAs) scan. The hybrid iterative reconstruction was used for the routine dose data while the DLR for data of reduced dose. The calcium score and risk categorization were compared, where the correlation was evaluated using the intraclass correlation coefficient (ICC). The noise suppression performance of DLR was characterized by the contrast-to-noise ratio (CNR) between coronary arteries and pericoronary fat.
The effective dose was 0.32 ± 0.03 vs. 0.48 ± 0.05 mSv for the two scans in group A and 0.09 ± 0.01 vs. 0.49 ± 0.05 mSv in group B. No significant difference was found on CACSs within either group (A: p = 0.10, ICC=0.99; B: p = 0.14, ICC=0.99), nor was it different on risk categorization (A: p = 0.32, ICC=0.99; B: p = 0.16, ICC=0.99). The DLR images exhibited higher CNR in both groups (A: p < 0.001; B: p = 0.001).
The DLR allowed reliable calcium scoring in not only low dose CSCT with reduced tube current but ultralow dose CSCT with simultaneously reduced tube voltage and current, showing feasibility to be adopted in routine applications.
探讨深度学习重建(DLR)在超低剂量钙评分CT(CSCT)中同时降低管电压和电流的潜力。
在这项前瞻性研究中,75例接受常规剂量CSCT(120kVp/30mAs)的患者(A组)随后进行低剂量(120kVp/20mAs)扫描,另外81例(B组)进行超低剂量(80kVp/20mAs)扫描。常规剂量数据采用混合迭代重建,降低剂量的数据采用DLR。比较钙评分和风险分类,并使用组内相关系数(ICC)评估相关性。DLR的噪声抑制性能通过冠状动脉与冠状动脉周围脂肪之间的对比噪声比(CNR)来表征。
A组两次扫描的有效剂量分别为0.32±0.03与0.48±0.05mSv,B组为0.09±0.01与0.49±0.05mSv。两组内的冠状动脉钙化积分(CACSs)均无显著差异(A组:p = 0.10,ICC = 0.99;B组:p = 0.14,ICC = 0.99),风险分类也无差异(A组:p = 0.32,ICC = 0.99;B组:p = 0.16,ICC = 0.99)。两组中DLR图像均显示出更高的CNR(A组:p < 0.001;B组:p = 0.001)。
DLR不仅能在降低管电流的低剂量CSCT中实现可靠的钙评分,还能在同时降低管电压和电流的超低剂量CSCT中实现可靠的钙评分,显示出在常规应用中的可行性。